A detailed history of First Turn Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, First Turn Management, LLC holds 255,294 shares of AXSM stock, worth $23.2 Million. This represents 3.63% of its overall portfolio holdings.

Number of Shares
255,294
Previous 337,246 24.3%
Holding current value
$23.2 Million
Previous $27.1 Billion 15.49%
% of portfolio
3.63%
Previous 4.42%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$78.93 - $95.84 $6.47 Million - $7.85 Million
-81,952 Reduced 24.3%
255,294 $22.9 Billion
Q2 2024

Aug 07, 2024

SELL
$65.72 - $80.5 $323,802 - $396,623
-4,927 Reduced 1.44%
337,246 $27.1 Billion
Q1 2024

May 03, 2024

BUY
$69.39 - $97.64 $3.24 Million - $4.56 Million
46,745 Added 15.82%
342,173 $27.3 Billion
Q4 2023

Feb 07, 2024

BUY
$57.42 - $83.61 $17 Million - $24.7 Million
295,428 New
295,428 $23.5 Billion

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.89B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track First Turn Management, LLC Portfolio

Follow First Turn Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Turn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Turn Management, LLC with notifications on news.